Literature DB >> 8862412

Genetic variation in neuraminidase genes of influenza A (H3N2) viruses.

X Xu1, N J Cox, C A Bender, H L Regnery, M W Shaw.   

Abstract

Nucleotide sequences of the neuraminidase (NA) genes of 33 influenza A (H3N2) epidemic strains isolated between 1968 and 1995 were analyzed to determine their evolutionary relationships. Phylogenetic analysis using the DNA maximum-likelihood method indicates that the NA genes of recent H3N2 field strains, like their hemagglutinin genes (HA), have evolved as two distinct lineages represented by the vaccine strains. A/Beijing/353/89 and A/Beijing/32/92 for A/Shanghai/24/ 90). Furthermore, genetic reassortment of NA genes between the two lineages occurred during their circulation. Genetic reassortants, which bear an A/Beijing/32/92-like HA and an A/Beijing/353/89-like NA, have circulated worldwide and are representative of current influenza A (H3N2) epidemic strains. The mutation rate of the NA gene was found to be 2.28 x 10(-3) per nucleotide site per year with 4.2% of the mutations resulting in amino acid substitutions. Thirty-five percent of the amino acid substitutions was located in sites previously suggested to be reactive to antibody. Amino acid residues involved in NA enzyme activity have been conserved. Seven potential glycosylation sites identified in the NA of A/Hong Kong/8/68 virus were conserved by the majority of isolates, with more recently circulating viruses having an additional glycosylation site. Comparison of the rate of amino acid substitutions in the NA stalk to that of entire NA revealed high variability in this region. These findings demonstrate the importance of closely monitoring both the HA and the NA genes of influenza viruses to aid vaccine strain selection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862412     DOI: 10.1006/viro.1996.0519

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Biological and protective properties of immune sera directed to the influenza virus neuraminidase.

Authors:  Stefan J Halbherr; Thomas H Ludersdorfer; Meret Ricklin; Samira Locher; Marianne Berger Rentsch; Artur Summerfield; Gert Zimmer
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  Viral evolution and epidemiology.

Authors:  Katrin Leitmeyer; Rebeca Rico-Hesse
Journal:  Curr Opin Infect Dis       Date:  1997-10       Impact factor: 4.915

4.  A practical approach to genetic screening for influenza virus variants.

Authors:  S Zou
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Toward a method for tracking virus evolutionary trajectory applied to the pandemic H1N1 2009 influenza virus.

Authors:  R Burke Squires; Brett E Pickett; Sajal Das; Richard H Scheuermann
Journal:  Infect Genet Evol       Date:  2014-07-24       Impact factor: 3.342

6.  Phylogenetic analysis of the entire genome of influenza A (H3N2) viruses from Japan: evidence for genetic reassortment of the six internal genes.

Authors:  S E Lindstrom; Y Hiromoto; R Nerome; K Omoe; S Sugita; Y Yamazaki; T Takahashi; K Nerome
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 7.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

8.  Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.

Authors:  Lianlian Jiang; Giovanna Fantoni; Laura Couzens; Jin Gao; Ewan Plant; Zhiping Ye; Maryna C Eichelberger; Hongquan Wan
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

9.  Identification of new influenza B virus variants by multiplex reverse transcription-PCR and the heteroduplex mobility assay.

Authors:  S Zou; C Stansfield; J Bridge
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

Authors:  Edwin D Kilbourne; Catherine Smith; Ian Brett; Barbara A Pokorny; Bert Johansson; Nancy Cox
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.